Skip to content
Non Regulatory

Alimak Group rights issue fully subscribed

The information in this press release is not intended for distribution, publication or public release, directly or indirectly, in or into, Australia, Canada, Japan, the United States or any other jurisdiction where the publication or distribution of this press release may be unlawful.

Please see the important notice at the end of this announcement.

Alimak Group AB's (publ) ("Alimak" or the "Company") share issue with preferential rights for the Company's shareholders has been fully subscribed. The subscription period for the rights issue ended on 31 March 2017. In the rights issue, 10,824,460 shares, corresponding to approximately 99.9 percent of the offered shares, have been subscribed for with subscription rights. In addition, applications for subscription without subscription rights of 4,634,008 shares have been received, corresponding to approximately 42.8 percent of the offered shares. The rights issue has thereby been oversubscribed. Through the rights issue, Alimak will receive proceeds amounting to approximately SEK 791 million before issue costs.

Those who have subscribed for shares without subscription rights will be allotted shares according to the principles outlined in the prospectus published on 13 March 2017. Notification regarding allotment of shares to subscribers who have been allotted shares without subscription rights are expected to be distributed on 6 April 2017. Subscribed and allotted shares shall be paid in cash at the latest on the settlement day, 11 April 2017, in accordance with the instructions on the settlement note. Nominee registered shareholders will receive notification regarding allotment of shares in accordance with the respective nominee's procedures. Only those who are allotted shares will be notified.

Through the rights issue Alimak's share capital will increase by SEK 216,631.44 from SEK 866,525.78 to SEK 1,083,157.22 and the total number of shares will increase by 10,831,572 shares from 43,326,289 shares to 54,157,861 shares, when the rights issue has been registered by the Swedish Companies Registration Office.

The new shares subscribed for with subscription rights are expected to start trading on Nasdaq Stockholm on Tuesday 11 April 2017. New shares subscribed for without exercise of subscription rights are expected to start trading on Nasdaq Stockholm on Thursday 20 April 2017.


Handelsbanken Capital Markets is acting as financial advisor and Hannes Snellman Attorneys is acting as legal advisor to Alimak in relation to the rights issue.


For further information, contact:

Per Ekstedt, CFO, Phone +46 8 402 14 57

Sofia Wretman, Head of Communications & IR, Phone: +46 8 402 14 41

This information is information that Alimak Group AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 18:00 CET on 5 April 2017.

About Alimak Group

Alimak Group is a world-leading provider of vertical access solutions for industrial and construction industries. With presence in more than 100 countries, Alimak develops, manufactures, sells and provides service to vertical access solutions with focus on adding customer value through greater safety, higher productivity and improved cost efficiency. The Group's products and solutions are sold under the brands Alimak Hek, CoxGomyl, Manntech and Avanti. Alimak has an installed base of more than 60,000 elevators, hoists, platforms, service lifts and building maintenance units around the world. Founded in Sweden 1948 Alimak has its headquarters in Stockholm, 12 manufacturing facilities in 8 countries and 2,400 employees around the world.